Abstract 4143671: Transcatheter Annuloplasty of Tricuspid Regurgitation with the K-Clip System: One-Year Results from the TRISTAR Study.

QINCHUN JIN,XIAOCHUN ZHANG,DAXIN ZHOU
DOI: https://doi.org/10.1161/circ.150.suppl_1.4143671
IF: 37.8
2024-01-01
Circulation
Abstract:Background: Despite progressively high morbidity and mortality rates associated with severe tricuspid regurgitation (TR), limited treatment options are available. Aims: The single-arm, multicenter, prospective TRISTAR study(K-Clip Transcatheter Annuloplasty System in Tricuspid Regurgitation(TRISTAR) Early Feasibility Study) evaluated the 1-year outcomes of the novel transcatheter K-Clip reconstruction system in treating secondary TR. Methods: Between May 2022 and October 2022, patients with ≥severe secondary TR at 11 centers, despite medication therapy, were deemed candidates for transcatheter tricuspid repair by the local Heart Team and a multidisciplinary screening committee. Results: Ninety-six patients were enrolled(mean age 72.7±7.1 years, 60.4% female, mean TRISCORE 5.3±2.1). Technical success and procedural success were achieved in 97.9% and 93.8%. At 1 year, echocardiography showed average reductions of annular septolateral diameter by 11.3% (41.9mm vs. 37.1mm, p < 0.001) with increases in stroke volume(60.8±18.5mL vs 67.6±19.8mL, p < 0.001) and cardiac output(4.3±1.5 vs 5.3±2.0, p < 0.001). Tricuspid regurgitation was reduced to ≤moderate in 82.5% with ≥1-grade reduction in 97.7% and ≥2-grade reduction in 66.3%. Patients experienced significant clinical improvements in New York Heart Association (NYHA) functional class I/II (32.6% to 96.5%, p < 0.001). Six-minute walk test increased by 31.9m(304.3±81.2, p<0.001), and overall Kansas City Cardiomyopathy Questionnaire (KCCQ) score improved by 7.6 points(66.7±16.89 vs 74.4±13.6, p<0.001). No cardiovascular mortality was reported while severe bleeding was reported in 5 patients. Kaplan-Meier estimated of survival and freedom from heart failure re-hospitalization were 97.8% and 95.1%, respectively. Conclusions: One-year experience using the K-Clip tricuspid annuloplasty system demonstrated high survival rates, low complications and durable improvements in TR reduction, functional status, and quality of life for patients with severe secondary TR.
What problem does this paper attempt to address?